Covalent modification of the active site threonine of proteasomal β subunits and the Escherichia coli homolog HslV by a new class of inhibitors

  1. Matthew Bogyo*,,
  2. John S. McMaster*,
  3. Maria Gaczynska*,
  4. Domenico Tortorella*,
  5. Alfred L. Goldberg, and
  6. Hidde Ploegh*,§
  1. *Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; and Department of Cell Biology, Harvard Medical School, Boston, MA 02115

Abstract

The proteasome is a multicatalytic protease complex that plays a key role in diverse cellular functions. The peptide vinyl sulfone, carboxybenzyl-leucyl-leucyl-leucine vinyl sulfone (Z-L3VS) covalently inhibits the trypsin-like, chymotrypsin-like and, unlike lactacystin, also the peptidylglutamyl peptidase activity in isolated proteasomes, and blocks their function in living cells. Although described as a class of mechanism-based inhibitors for cysteine proteases, the peptide vinyl sulfone Z-L3VS and a 125I-labeled nitrophenol derivative (125I-NIP-L3VS) covalently modify the active site threonine of the catalytic β subunits of the proteasome. Modification of Thermoplasma proteasomes demonstrates the requirement for a hydroxyl amino acid (threonine, serine) as nucleophile at the β subunit’s NH2 terminus. 125I-NIP-L3VS covalently modifies the HslV subunit of the Escherichia coli protease complex HslV/HslU, a reaction that requires ATP, and supports a catalytic mechanism shared with that of the eukaryotic proteasome.

Footnotes

  • e-mail: boge{at}mit.edu.

  • § To whom reprint requests should be addressed. e-mail: ploegh{at}mit.edu.

  • Herman N. Eisen, Massachusetts Institute of Technology, Cambridge, MA

  • ABBREVIATIONS:
    Z-L3VS,
    carboxybenzyl-leucyl-leucyl-leucine vinyl sulfone;
    125I-NIP-L3VS,
    125I-labeled nitrophenol derivative;
    MHC,
    major histocompatibility complex
« Previous | Next Article »Table of Contents